Monoclonal antibodies to a 100-kd protein reveal abundant Aβ-negative plaques throughout gray matter of Alzheimer's disease brains

American Journal of Pathology

Volumn 151, Issue 1, 1997, Pages 69-80

  Schmidt, Marie Luise ^a   Lee Virginia, M Y ^a   Forman, Mark ^a   Chiu, Ting Shan ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CLINICAL ARTICLE; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CEREBRAL CORTEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEUROFIBRILLARY TANGLES; PROTEINS;

EID: 0030871478     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Goedert M, Trojanowski JQ, Lee VM-Y: The neurofibrillary pathology of Alzheimer's disease. The Molecular and Genetic Basis of Neurological Disease, ed. 2. Edited by SB Prusiner, S DiMauro, RL Barchi. Boston, Butterworth Heineman Press, 1997, pp 613-628
2. Trojanowski JQ, Clark CM, Schmidt ML, Aral H, Zhu C, Mawal-Dewan M, Lee VM-Y: Implications of tau-rich neurofibrillary lesions for the pathobiology and diagnosis of Alzheimer's disease. Current Neurology. Edited by S Appel. Mosby-Year Book, St. Louis, 1996, pp 93-113
3. Selkoe DJ: Cell biology of the amyloid -protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994, 10:373-403
4. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995, 89:35-41
5. Dickson DW: Apoptosis in the brain. Am J Pathol 1995, 146:1040-1044
6. Busciglio J, Yankner BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1996, 378:776-779
7. Bancher C, Jellinger K, Lassmann H, Fischer P, LebIhuber F: Correlations between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur Arch Psychiatry Clih Neurosci 1996, 240:137-146
8. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo Y-M, Rohrer AE: Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 1996, 16:6021-6037
9. Pollak SJ, Sadler IIJ, Hawtin SR, Tailor VJ, Shearman MS: Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion. Neurosci Lett 1995, 197:211-214
10. Iversen LL, Mortishire-Smith RJ, Pollak SJ, Shearman MS: The toxicity in vitro of β-amyloid protein. Biochem J 1995,311:1-16
11. Yankner BA: Amyloid fibril toxicity and tau hyperphos-phorylation in Alzheimer's disease: cell culture and animal models. ISN Satellite Meeting 1995, pp 62-66
12. Garden MJ, Schlaepfer WW, Lee VM-Y: The structure, biochemical properties and immunogenicity of neurofilament peripheral regions are determined by phosphorylation. J Biol Chem 1985, 260:9805-9817
13. Lee VM-Y, Garden MJ, Schlaepfer WW: Structural similarities and differences between neurofilament proteins from five different species as revealed by monoclonal antibodies. J Neurosci 1986, 6:2179-2186
14. Lee VM-Y, Garden MJ, Trojanowski JQ: Novel monoclonal antibodies provide evidence for the in situ existence of a non-phosphorylated form of the largest neurofilament subunit. J Neurosci 1986, 6:850-858
15. Lee VM-Y, Page CD, Wu H-L, Schlaepfer WW: Monoclonal antibodies to gel excised glial filament protein and their reactivity with other intermediate filaments. J Neurochem 1984, 42:25-32
16. Bramble GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y: Abnormal tau phosphorylation at ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099
17. Shin R-W, Bramblett GT, Lee VM-Y, Trojanowski JQ: Alzheimer disease A68 proteins injected into rat brain induce codeposits of β-amyloid, ubiquitin and a1-antichymotrypsin. Proc Natl Acad Sci USA 1993, 90:68256828
18. Greenberg SG, Davies P, Schein JD, Binder LI: Hydrofluoric acid-treated TPHF proteins display the same biochemical properties as normal T. J Biol Chem 1992, 267:564-569
19. Lang E, Szendrei Gl, Lee VM-Y, Otvos L Jr: Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem Biophys Res Commun 1992, 187:783-790
20. Lee VM-Y. Balin BJ, Otvos L Jr, Trojanowski JQ: A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991, 251:675-678
21. Turner RS, Suzuki N, Chyung AS, Younkin SG, Lee VM-Y: Amyloids β40 and 042 are generated intracellularly in cultured human neurons, and their secretion increases with maturation. J Biol Chem 1996, 271: 8966-8970
22. Schmidt ML, DiDario AG, Otvos L Jr, Hoshi N, Kant A, Lee VM-Y, Trojanowski JQ: Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp Neurol 1994, 130:311-322
23. Kirn KS, Miller DL, Sapienza VJ, Chen CJ. Bai C, Grundke-lqbal I, Currie JR, Wisniewski HM: Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 1988, 2:121-130
24. Kim KS, Wen GY, Bancher C, Chen CMJ, Sapienza VJ, Hong H, Wisniewski HM: Detection and quantitation of amyloid β peptide with 2 monoclonal antibodies. Neurosci Res Commun 1990, 9:113-122
25. Delaere P, Duyckaerts C, Masters CL, Beyreuther K, Piette F, Hauw JJ: Large amounts of neocortical β/A4 deposits without neuritic plaques nor tangles in a psy-. chometrically assessed, nondemented person. NeurosciLett 1990, 116:87-93
26. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau A, Davies P, Yen S-H, Aronson MK: Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991, 13:179-189
27. Schmidt ML, Martin JA, Lee VM-Y, Trojanowski JQ: Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996, 91:475-481
28. Schmidt ML, Huang R, Martin JA, Henley J, MawalDewan M, Hurtig HI, Lee VM-Y, Trojanowski JQ: Neurofibrillary tangles in progressive supranuclear palsy contain the same epitopes identified in Alzheimer's disease PHF-tau. J Neuropathol Exp Neurol 1996, 55: 534-539
29. Davis RL, Robertson DM: A Textbook of Neuropathology. Baltimore, Williams and Wilkins, 1985
30. Vonsattel JP, Aizawa H, Ge P. DiFiglia M, McKee AC, MacDonald M, Gusella JF, Landwhermeyer GB, Bird ED, Richardson EP Jr, Hedley-Whyte ET: An improved approach to prepare human brain for research. J Neuropathol Exp Neurol 1995, 54:42-56
31. Schmidt ML, Lee VM-Y, Trojanowski JQ: Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am J Pathol 1990, 136: 1069-1075
32. Schmidt ML, Lee VM-Y, Trojanowski JQ: Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab Invest 1991, 64:352-357
33. Schmidt ML, Robinson KA, Lee VM-Y, Trojanowski JQ: Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol 1995, 147:503-515
34. Matsuo ES, Shin R-W, Billingsley ML, Van de Voorde A, O'Connor M, Trojanowski JQ, Lee VM-Y: Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994, 13:989-1002
35. Mawal-Dewan M, Schmidt ML, Baiin B, Perl DP, Lee VM-Y, Trojanowski JQ: Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/Parkinsonism-dementia complex. J Neuropathol Exp Neurol 1996, 55:10511059
36. Bramblett GT, Trojanowski JQ, Lee VM-Y: Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent T and accumulations of abnormal r-isoforms (A68 proteins). Lab Invest 1992, 66:212-222